John C. Davis, Jr.
2020
In 2020, John C. Davis, Jr. earned a total compensation of $1.8M as Head of Research and Development and Chief Medical Officer at Dianthus Therapeutics, a 93% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,000 |
|---|---|
| Option Awards | $1,153,528 |
| Salary | $445,376 |
| Other | $1,256 |
| Total | $1,762,160 |
Davis received $1.2M in option awards, accounting for 65% of the total pay in 2020.
Davis also received $162K in non-equity incentive plan, $445.4K in salary and $1.3K in other compensation.
Rankings
In 2020, John C. Davis, Jr.'s compensation ranked 6,101st out of 13,090 executives tracked by ExecPay. In other words, Davis earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,101 out of 13,090 | 53rd |
Division Manufacturing | 2,519 out of 5,621 | 55th |
Major group Chemicals And Allied Products | 1,011 out of 2,254 | 55th |
Industry group Drugs | 876 out of 1,954 | 55th |
Industry Pharmaceutical Preparations | 654 out of 1,459 | 55th |
Source: SEC filing on April 21, 2021.
Davis' colleagues
We found two more compensation records of executives who worked with John C. Davis, Jr. at Dianthus Therapeutics in 2020.